Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/REVIVE-THERAPEUTICS-LTD-62465380/news/Revive-Therapeutics-Ltd-Provides-Update-Evaluating-Bucillamine-for-Nerve-Agent-Exposure-with-Defenc-45752251/?utm_source=whatsapp&utm_medium=social&utm_campaign=share